New drug SSS67 begins first human tests
NCT ID NCT07487545
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This is an early-stage study testing a new drug, SSS67, in 52 healthy adults. The main goal is to see if it is safe and how the body handles it. Participants receive a single dose of SSS67 or a placebo by IV. The study also looks at how the drug affects bone markers and metabolism.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SSS67
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novatrials
Charlestown, New South Wales, 2290, Australia
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test